Arkolith/Insider Trading/INM/Form 4

Hsu Eric C

Sr. VP, Pre-Clinical Res/DevInMed Pharmaceuticals Inc. (INM) · full profile →Form 4 · filed Aug 31, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 31, 2023Expiration(H)327—$08K

Transaction Codes

H
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-072856) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML